Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation.
Senolysis Enabled by Senescent Cell-Sensitive Bioorthogonal Tetrazine Ligation.
复制标题
通过衰老细胞敏感的生物正交四嗪连接实现衰老分解。
DOI:
10.1002/anie.202315425
复制
发表时间:
2024
期刊:
影响因子:
--
通讯作者:
Wang,Wei
中科院分区:
文献类型:
--
作者:
Chang,Mengyang;Dong,Yue;Xu,Hang;Cruickshank-Taylor,AlexisB;Kozora,JacobS;Behpour,Baran;Wang,Wei
Although the clearance of senescent cells has been proven to slow down the aging process and promote anti‐cancer chemotherapy, the development of senolytics remains challenging. Herein, we report a senolytic strategy enabled by senescent cell‐sensitive bioorthogonal tetrazine ligation. Our design is based on linking dihydrotetrazine (Tz) to a galactose (Gal) moiety that serves both as a recognition moiety for senescence‐associated β‐galactosidase and a caging group for the control of tetrazine activity. Gal‐Tz enables efficient click‐release of a fluorescent hemicyanine and doxorubicin from atrans‐cyclooctene‐caged prodrug to detect and eliminate senescent HeLa and A549 cells over non‐senescent counterparts with a 16.44 senolytic index. Furthermore, we leverage the strategy for the selective activation and delivery of proteolysis‐targeting chimeras (PROTACs) as senolytics. PROTAC prodrug TCO‐ARV‐771 can be selectively activated by Gal‐Tz and delivered into senescent HeLa and A549 cells to induce the degradation of bromodomain‐containing protein 4. Senolytic PROTACs may offer an efficient way for intervention on cell senescence thanks to their unique capacity to degrade target proteins in a sub‐stoichiometric and catalytic fashion. The results of this study establish the bioorthogonal tetrazine ligation approach as a viable strategy for selective removal of senescent cells.